Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- DNA test says it can predict opioid addiction risk. Skeptics aren’t so sure.
- Transfer Scholars Initiative prepares N.J. community college students to thrive at selective four-year schools.
- Scientists May Have Discovered Reason for Long COVID Brain Fog—Here’s Why It Matters.
- Are You at Risk for Addiction?
- NJ health inequities are focus of Rutgers symposium.